3Cs干预提高COPD患者流感与肺炎球菌疫苗接种率:一项随机对照试验
3Cs-Based intervention to improve influenza and pneumococcal vaccination in COPD patients: An RCT
在贵州省人民医院开展的随机对照试验显示,基于3Cs模型设计的医防融合干预措施能显著降低COPD患者的疫苗犹豫并提高接种率。纳入256名受试者,干预组流感疫苗(InfV)和肺炎球菌多糖疫苗(PPV)的犹豫率及接种率均显著优于对照组。例如,InfV接种率在干预组为54/128,对照组为12/128。
- Article
- Open access
- Published: 23 October 2026
npj Primary Care Respiratory Medicine (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
To explore the impact of integrated medical and preventive interventions—comprising vaccine health promotion materials and a “vaccine health prescription” designed based on the 3Cs vaccine hesitancy model, led by CDC departments and implemented by hospital respiratory physicians—on the knowledge levels and vaccination rates of influenza vaccine (InfV) and pneumococcal polysaccharide vaccine (PPV) among COPD patients. Using convenience sampling, we recruited COPD patients who met the inclusion and exclusion criteria from the respiratory outpatient department of Guizhou Provincial People’s Hospital from June 2025 to January 2026 as study subjects. Inclusion criteria: (1) Aged ≥18 years and meeting COPD diagnostic criteria (post-bronchodilator FEV1/FVC < 0.70) with exclusion of other diseases; (2) Permanent residents of Guiyang City (referring to both registered and non-registered residents who have resided for more than half a year); (3) Meet the indications for InfV and/or PPV vaccination; (4) Voluntarily participate in the research and sign the informed consent form. Exclusion criteria: (1) Patients with contraindications to vaccination; (2) Patients who are unable to complete the questionnaire or refuse to participate in the study; (3) Patients who were vaccinated with InfV in 2025 and with PPV during the period from 2021–2025. A medical-prevention integrated intervention strategy designed by the Guizhou Provincial Center for Disease Control and Prevention based on the 3Cs vaccine hesitancy model, and implemented by respiratory outpatient doctors at Guizhou Provincial People’s Hospital.Outpatient doctors collected relevant information from COPD patients through questionnaires. Patients were randomly assigned to the control group and the intervention group. Vaccine hesitancy refers to the behavior of delaying or refusing vaccination when vaccines are available. The 3Cs model of vaccine hesitancy includes three dimensions: Confidence, Complacency, and Convenience. Confidence refers to the level of trust that individuals have in the safety and efficacy of vaccines, the healthcare system, and policymakers; Complacency refers to the perception that one is at low risk of infection, or the underestimation of the risk of vaccine-preventable diseases, leading individuals to believe that vaccination is unnecessary; Convenience refers to the accessibility of vaccination, including geographical reach, economic cost, service hours, and ease of procedures.The intervention group received vaccine health education based on the 3Cs model and were recommended a “vaccine health prescription” for receiving InfV and PPV. The control group did not receive the aforementioned interventions. A second questionnaire survey was conducted by telephone one month after the patient was enrolled. Query the actual administration of InfV and PPV within 6 months after patient enrollment through the vaccination service system. The primary outcomes observed were InfV and PPV vaccination rates, hesitancy rates, and changes in the three dimensions of the 3Cs model. Of the 265 initially enrolled subjects, 9 were lost to follow-up (3.4%), leaving 256 for analysis (128 in each group). Post-intervention, hesitancy rates for InfV were significantly lower in the experimental group than in the control group (21/128 vs 45/128), hesitancy rates for PPV were significantly lower in the experimental group than in the control group (31/128 vs 60/128) ; vaccination rates for InfV were significantly higher in the experimental group than in the control group(54/128 vs 12/128), PPV vaccination coverage within the previous 5 years were significantly higher in the experimental group than in the control group(42/128 vs 12/128). Health promotion materials and ‘vaceine health preseriptions’ designed based on the 3C’s vaecine hesitancymodel, led by the CDC and implemented by hospital respiratory physicians, as part of a medical.prevention integrated intervention, can reduce vaccine hesitaney for Infv and PpV among COPD patients.increase awareness ofthe 3Cs, and improve vaccination rates.
Funding
Noncommunicable Chronic Diseases—National Science and Technology Major Project (2026ZD0557506). Interdisciplinary Talents in Medicine, Disease Prevention and Control, and Governance Training Programme of the National Health Commission of China (GWBRH[2025]279). “Healthy Living, Scientific Management” – Community Health Management Science Popularization Project of Guizhou Provincial Association for Science and Technology(SQJKGL-202501). Investigation and Path Exploration of the Integration Status of Medical Prevention Collaboration in Guizhou (QKX2025-ZX-003). Guizhou Provincial Health Commission Science and Technology Fund Project (gzwkj2026-078).
Author information
Authors and Affiliations
Guizhou Center for Disease Control and Prevention, Guiyang, China
Zhengli Tang, Dan Xu & Yuandong Hu
Guizhou Medical University, Guiyang, China
Hongju Li
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Binshan Jiang
State Key Laboratory of Respiratory Health and Multimorbidity, Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Beijing, China
Binshan Jiang
Chinese Center for Disease Control and Prevention & Chinese Academy of Preventive Medicine, Beijing, China
Li Li
Guizhou Provincial People’s Hospital, Guiyang, China
Cheng Zhang
Authors
- Zhengli Tang
- Hongju Li
- Binshan Jiang
- Li Li
- Dan Xu
- Cheng Zhang
- Yuandong Hu
Corresponding authors
Correspondence to Cheng Zhang or Yuandong Hu.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Tang, Z., Li, H., Jiang, B. et al. 3Cs-Based intervention to improve influenza and pneumococcal vaccination in COPD patients: An RCT. npj Prim. Care Respir. Med. (2026). https://doi.org/10.1038/s41533-026-00559-6
Received: 19 March 2026
Accepted: 21 August 2026
Published: 23 October 2026
DOI: https://doi.org/10.1038/s41533-026-00559-6
来源:Nature 健康护理主题 · nature.com